Inhibrx, Inc.

INBX - Company ID 0001739614

Market cap$1.53 B

Rank#2344

Filings261

Inhibrx, Inc. has filed 261 public company documents between 2018 and 2024. The most frequent type is insider trade (70 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchINBX overview$1.53 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2344See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with AMGNPeer viewPut INBX beside AMGN across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow INBX via RSS

Similar companies to research next

AMGNAmgen Inc.

GILDGilead Sciences, Inc.AARGXargenx SE RRVMDRevolution Medicines, Inc.

MRNAModerna, Inc.

BIIBBiogen Inc.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
8-K	Major company event	5y ago2020-11-13	2020-11-13	View filing
10-Q	Quarterly report	5y ago2020-11-13	2020-09-30	View filing
8-K	Major company event	5y ago2020-11-12	2020-11-11	View filing
8-K	Major company event	5y ago2020-09-11	2020-09-11	View filing
SC 13G	Passive ownership stake	5y ago2020-08-31	-	View filing
4	Insider trade	5y ago2020-08-28	2020-08-26	View filing
4	Insider trade	5y ago2020-08-25	2020-08-21	View filing
3	New insider ownership	5y ago2020-08-25	2020-08-21	View filing
4	Insider trade	5y ago2020-08-24	2020-08-21	View filing
4	Insider trade	5y ago2020-08-21	2020-08-21	View filing
4	Insider trade	5y ago2020-08-21	2020-08-21	View filing
8-K	Major company event	5y ago2020-08-21	2020-08-21	View filing
S-8	Employee stock plan	5y ago2020-08-19	-	View filing
424B4	424B4	5y ago2020-08-19	-	View filing
EFFECT	EFFECT	5y ago2020-08-18	-	View filing
S-1MEF	S-1MEF	5y ago2020-08-18	-	View filing
3	New insider ownership	5y ago2020-08-18	2020-08-18	View filing
3	New insider ownership	5y ago2020-08-18	2020-08-18	View filing
3	New insider ownership	5y ago2020-08-18	2020-08-18	View filing
3	New insider ownership	5y ago2020-08-18	2020-08-18	View filing
3	New insider ownership	5y ago2020-08-18	2020-08-18	View filing
3	New insider ownership	5y ago2020-08-18	2020-08-18	View filing
3	New insider ownership	5y ago2020-08-18	2020-08-18	View filing
3	New insider ownership	5y ago2020-08-18	2020-08-18	View filing
3	New insider ownership	5y ago2020-08-18	2020-08-18	View filing
CERT	Exchange certification	5y ago2020-08-17	-	View filing
8-A12B	8-A12B	5y ago2020-08-14	-	View filing
CORRESP	Company correspondence	5y ago2020-08-14	-	View filing
CORRESP	Company correspondence	5y ago2020-08-14	-	View filing
SEC STAFF LETTER	SEC STAFF LETTER	5y ago2020-08-13	-	View filing
S-1/A	S-1/A	5y ago2020-08-12	-	View filing
SEC STAFF LETTER	SEC STAFF LETTER	5y ago2020-08-06	-	View filing
CORRESP	Company correspondence	5y ago2020-08-05	-	View filing
UPLOAD	SEC correspondence	5y ago2020-08-05	-	View filing
CORRESP	Company correspondence	5y ago2020-08-03	-	View filing
S-1	IPO registration	5y ago2020-07-28	-	View filing
CORRESP	Company correspondence	5y ago2020-07-27	-	View filing
UPLOAD	SEC correspondence	5y ago2020-07-24	-	View filing
DRS	DRS	6y ago2020-06-26	-	View filing
D	D	6y ago2020-04-16	-	View filing

Inhibrx, Inc.

Similar companies to research next

Year